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Stroke was the second most frequent cause of death worldwide in 2012, accounting for 6.7 million deaths.(1) Approxi-
mately 17 million people had a stroke in 2010 and 33 million people have previously had a stroke and were still alive 
making total population of 50 million with stroke in the world.(2) Stroke is the number one preventable cause of permanent 
disability.(3)Projections show that by 2030, stroke prevalence will increase by more than 20% over 2012. (3) The World 
Health Organization (WHO) definition (1970) of stroke“rapidly developing clinical signs of focal (or global) disturbance 
of cerebral function,lasting more than 24 hours or leading to death, with noapparent cause other than that of vascular 
origin” is still frequently used.(4) This definition has been accepted by neurology community for more than 40 years 
despite many pitfalls. Firstly, this definition stresses on focal or global cerebral dysfunction and did not include stroke 
caused bybrainsten, retinal or spinal cord vascular events. Secondly, few vascular events may present with headache 
without causing focal or global cerebral dysfunction such as mild cases of cerebral venous thrombosis and subarachnoid 
hemorrhage and would not fulfill this WHO definition. Thirdly, old definition also did not address silent infarction and 
silent cerebral hemorrhage found on neuroimaging or neuropathological examination.Fourthly, another component of 
this definition i.e. “global cerebral dysfunction” occurs only in special setting such as severe hypotension and after a 
period of cardiac arrest causing global cerebral ischemia and, in strict sense, is not a stroke syndrome. As a result 
oldest WHO definition of stroke has become outdated, obsolete and needed reformulation. First definition of transient 
ischemic attacks “TIAs” was proposed in 1964 by J. Marshall and defined such attacks as “a disturbance of neurological 
function of less than 24 hours’ duration occurring in the territory of supply of the carotid or vertebrobasilar arteries.”(5) 
In 1975, an Ad Hoc Committee on Cerebrovascular Disease published the following definition: “Transient ischemic 
attacks are episodes of temporary and focal dysfunction of vascular origin, which are variable in duration, commonly 
lasting from 2 to 15 minutes, but occasionally lasting as long as a day (24 hours). They leave no persistent neurological 
deficit”.(6) When this definition was formulated, diagnostic techniques were unavailable that could determine the 
presence of brain infarction. The definition of TIA that was used in the 1975 report was universally cited until the beginning 
of the 21st century. There were two pitfalls in old definition of TIAs: duration of TIAs and lack of imagingfindings. As 
neurological deficit may recover completely clinicallywith in24 hours but imaging may show evidence of infarction. 
Frequency of DWI abnormality in patients withtransient neurological episodes of different durations was found between 
30-51% in a pooled analysis from 10 MRI Studies enrolling 818 patients.(7) During the last 40 years, lot of development 
and progress has been made in understanding stroke and therapeutic approaches to stroke.New techniques in imaging 
have been developed with better understanding of stroke syndrome that has prompted attempts at new redefinition of 
“Stroke” and “TIAs”.The Stroke Council of the American Heart Association/American Stroke Association convened a 
writing group to develop an expert consensus document for an updated definition of stroke for the 21st century. In this 
editorial I would highlight some of these new definitions of stroke related syndromes as formulated by expert panel and 
has already been published in journal of “Stroke”.(8) The updated definition of stroke incorporates clinical and tissue 
criteria especially imaging. The term “Stroke” is broadly applicable to include all cases of CNS infarction, intracerebral 
hemorrhage, and subarachnoid hemorrhage. Central nervous system infarction is defined as brain, spinal cord, or 
retinal cell death attributable to ischemia, based on neuropathological, neuroimaging, and/or clinical evidence of 
permanent injury (i.e symptoms persisting ≥24 hours or until death, and other etiologies excluded). CNS infarction also 
includes hemorrhagic infarctions, types I and II. Ischemic stroke specifically refers to central nervous system infarction 
accompanied by overt symptoms. Almost 50 years ago, Fisher first described the presence of cerebral infarction in the 
absence of any clinically apparent stroke or transient ischemic attack. (9) It is only in recent years with major advances 
in imaging technology, however, that ‘silent’ brain infarcts (SBI) have been studied in any detail. Silent CNS infarction 
is defined as imaging or neuropathological evidence of CNS infarction, without a history of acute neurological dysfunction 
attributable to the lesion.The prevalence of SBI ranges from 5% to 62% in populationbased cohorts, most estimates 
falling in the 10% to 20% range. Longitudinal studies suggest an annual incidence between 2% and 4%. (10) Silent 
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brain infarcts increase the risk of clinical infarction by 2 to 4 times in population-based studies.(11) This led to incorporation 
of brain infarction into the ABCD system (ABCD2I score) which improved prediction of stroke in the acute phase after 
transient ischemic attack.(12) The presence of hemorrhage in ischemic infarction has forced many treating physicians 
to stop ischemic treatment till hemorrhage is resolved. This hemorrhagic transformation of ischemic infarction has also 
been more clearly defined in two categories i.e. hemorrhagic infarction and parenchymal hemorrhage with clear guidelines 
regarding continuation or discontinuation of anti thrombotic treatment. “Hemorrhagic infarction” is defined as hemorrhage 
that may occur after infarction, either spontaneously or caused by antithrombotic or thrombolytic therapy. Hemorrhagic 
infarction is characterized by its lack of mass effect. Hemorrhagic infarction type I is defined by petechiae of blood along 
the margins of the infarction, whereas type II has confluent petechiae within the infarction but without a space occupying 
effect. Despite presence of hemorrhage these patients are treated according to ischemic protocol and are considered 
cerebral infarctions.In contrast, parenchymal hemorrhage is defined by the presence of mass effect, similar to the ICH 
definition of a focal collection of blood. Parenchymal hemorrhage type-I is a confluent hemorrhage limited to ≤30% of 
the infarcted area with only mild space-occupying effect, and type II is >30% of the infarcted area and/or exerts a 
significant space-occupying effect. These parenchymal hemorrhages parenchymal hemorrhages should be considered 
ICHs and may require reversal of antithrombotic therapy, aggressive antihypertensive therapy, and/or anti-edema 
therapy’.Similary stroke due to intracerebralhemoorhage, Subarachnoid hemorrhage, Cerebral venous thrombosis and 
Stroke, not otherwise specified has been redfined by the expert panel.(8) At the end I would like to highlight recent 
definitions of TIA. In 2002, an expert committee proposed a new definition: “A TIA is a brief episode of neurologic 
dysfunction caused by focal brain or retinal ischemia, with clinical symptoms typically lasting less than one hour, and 
without evidence of acute infarction”.(13) In 2009, an expert committee of the American Heart Association/American 
Stroke Association published a scientific statement defining TIA and recommending evaluation. The definitionof  transient 
ischemic attack (TIA) proposed was: “a transient episode of neurological dysfunction caused by focal brain, spinal cord, 
or retinal ischemia without acute infarction”.(14) Because of the variability of duration ; there is now general agreement 
that a fixed time designation should not be the primary distinguishing factor between stroke and TIA. Time should be a 
secondary consideration when adequate imaging is unavailable. Future implications of new definitions for physicians in 
Pakistan. The new definitions rely more on imaging techniques especially DWI and / or PWI MRI which can detect infarction 
within few minutesafter the arterial occlusion and even in patients who had transient vascular event on clinical ground.  
In Pakistan, neurological services are available only in main teaching hospitals and MRI facilities are limited to major 
cities. More over the use of thrombolytic therapy for acute stroke is even rare in the country. Under these circumstances 
treating physician would have no choice to adhere to the older definitions which are more clinical than imaging or tissue 
based. How we need to develop the neurological services in the country and update the knowledge of physicians with 
new trends and development in the world.
INTRODUCTION
Stroke is one of the most leading causes of mortality 
and disability in the world. (1) Many patients are left with 
residual cognitive deficits such as personality disorders, 
depression and memory loss after acute phase of 
stroke (2, 3). Post stroke dementia (PSD) is the second 
most common cause of dementia (4) and one of the 
main causes of dependency in survivors and includes 
any dementia after a stroke, irrespective of its cause (5). 
In Europe and North America, Alzheimer's disease 
predominates over PSD in a 2:1 ratio; in contrast, in 
some Asian countries PSD accounts for almost 50% of 
all dementias (6). Its prevalence ranges from 6 to 32% (7) 
and it has been found to be higher than previously 
expected, and a stroke increases the risk of dementia 4 
to 12 times (8). The diagnosis of PSD is based on the 
patient history, the clinical evaluation and neuroimaging 
(9), and it is   associated with high rates morbidity and 
mortality (2). Then, it is important to determine its risk 
factors. Some demographic, genetic and lesion-related 
radiological factors have been reported to predict 
dementia in stroke patients, but there has not been a 
consensus about them  (10, 11). Realizing the importance 
of research in this filed and lack of any published 
studies  about PSD from Iran , we decided to evaluate 
the prevalence of PSD  and some of  its putative  risk  
factors. To our knowledge, this is the first hospital-
based study among Iranian population about PSD.
METHODS 
1. Subjects 
This cross-sectional study was conducted on 151 
patients with first-ever stroke in Rafsanjan (south of 
Iran). Patients with a clinical suspicion of stroke under-
went neuroimaging (CT scan and MRI) and the diagnosis 
was confirmed by them. All patients with history of any 
underling disease especially dementia and mild cognitive 
impairment were excluded from the study except 
patients with ischemic heart disease (IHD), diabetes 
(DM), hypertension (HTN) and hyperlipidemia (HLP). 
Other exclusion criteria were history of opium or other 
substance addiction, inadequate vision and hearing, 
aphasia   any drug consumption (except drugs were 
used for treatment of IHD, DM, HTN, HLP) such as 
antipsychotic and anti depressant. The ethics committee 
of Yazd branch of Islamic Azad University had confirmed 
the research. 
2. Clinical characteristics
Following information was collected for each patient: 
baseline demographics (age, gender and educational 
status), stroke type according to Oxfordshire Community 
Stroke Project Classification. The subjects were 
screened for PSD using the DSM-IV at three months.
3. Statistical analysis
To analyze the data, descriptive statistics, and 
chi-square test were used and p≤0.05 was considered   
statistically significant.
RESULTS 
In our study, 71(47%) patients were male and the rest 
were80 (53%) female. Mean age of men and women 
were 65.5 and 66.5 years, respectively. 35 (23.2%)   
patients had PSD after three months. 70.6 % of 
patients were 60 years old or more. 88.7% of patients 
had ischemic infarction and the others had hemor-
rhagic stroke. The most frequent lesion locations were 
temporal, frontal and parietal lobes respectively. There 
was no significant statistical difference between PSD 
and sex, age, educational status, lesion location and 
kind of stroke. (Table 1)
Table1: Frequency of risk factors in patients 
CONCLUSION
In our hospital-based study prevalence of PSD was 
23.2 % . This finding shows that a significant portion of 
patients with stroke are prone to PSD. We did not find 
any published article about PSD concerning the Iranian 
population; it seems that in Iranian population, our 
study is the first in this field but many studies have been 
conducted in other countries. Prevalence of PSD is 
reported to be between 7% and 41%, (10). Some studies 
show the same frequency of PSD as our study, such as 
those conducted in Italy (24.6%) and America (26.3%) 
(12,13 ) where as others show lower prevalence such as 
Portugal( 5.9% ) and Taiwan( 9.2%) (14, 15) or higher in 
Finland (31.8%) (16). In a systematic review ,the prevalence 
of post stroke memory dysfunction varied from 23% to 
55% 3 months post stroke, which declined from 11% to 
31% 1 year post stroke.(17 ). The prevalence of dementia 
among people with a history of stroke is similar to that 
observed in subjects 10 years older without a history of 
stroke (18). Also, several studies have confirmed that 
stroke doubles the probability of developing dementia 
and that risk is higher in the first 6-12 months and in a 
community based study done over 25 years, the cumu-
lative incidence of PSD was 7% after 1 year, 10% after 
3 years, 15% after 5 years, 23% after 10 years, and 
48% after 25 years (19 ) These discrepancies may be   
related to different population studies, different criteria 
used for the diagnosis of dementia  and different time 
interval between stroke and the neuropsychological 
assessment (20). Although, stroke was recognized as an 
important cause of dementia more than a century ago 
(21), many aspects of PSD pathophysiology are not clear. 
The causes of PSD are multifactorial and involve 
neuronal networks needed for memory (22). Disturbance 
in some neurotransmitters (6), genetic factors (23), direct 
neuronal damage and impaired vascular autoregulatory 
mechanisms are some factors involved in PSD pato-
physiology. (2, 24, 25) Our results showed that PSD can be 
seen in both ischemic and hemorrhagic lesions. The 
risk and severity of cognitive disturbances occurring 
after a stroke do not seem to be influenced by type of   
stroke (ischemic or hemorrhagic) (8, 13, 14). In most 
studies such as ours, no gender specifity was observed 
(15,21). Similarly, many studies did not find any relation-
ship between location of the vascular lesion and PSD 
(14,15,21). Higher educational attainment has been found 
to be a protective factor for PSD (5) however, we could 
not ascertain this effect in our study and neither could 
the research performed in Spain (21). Although we did 
not find a relationship between age and dementia, 
some have studies suggested an association between 
the two (11, 21). It should be mentioned that  controversies 
about age, sex, location of lesion and educational 
status are frequent(7 ,11), and some factors such as  
dysphasia, hemiparesis, hemianopia (10), silent infarcts, 
cortical cerebral atrophy (26) medial temporal lobe atrophy 
and white matter changes , have been associated with 
an increased risk to develop PSD in some studies(19). 
Our study had some limitations. First, our study was a 
cross-sectional study. Second; we fallowed the patients 
only three months. Third, patients with aphasia were 
excluded from our study. These limitations may have 
some effects on the results. In conclusion, our study 
showed high prevalence of PSD in Iranian population. 
Both ischemic and hemorrhagic lesions have a similar 
effect on PSD and early recognition and treatment of 
PSD risk factors will definitely improve the quality of life 
of the patients.  
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JOURNEY OVER FOUR DECADES TO DISCOVER NEW
DEFINITIONS OF STROKE AND TIA FOR 21ST CENTURY: 
ARE WE READY FOR THE CHANGE?
( v ) V O L .  1 0  ( 1 )  J A N   -   M A R C H   2 0 1 5P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S
Stroke was the second most frequent cause of death worldwide in 2012, accounting for 6.7 million deaths.(1) Approxi-
mately 17 million people had a stroke in 2010 and 33 million people have previously had a stroke and were still alive 
making total population of 50 million with stroke in the world.(2) Stroke is the number one preventable cause of permanent 
disability.(3)Projections show that by 2030, stroke prevalence will increase by more than 20% over 2012. (3) The World 
Health Organization (WHO) definition (1970) of stroke“rapidly developing clinical signs of focal (or global) disturbance 
of cerebral function,lasting more than 24 hours or leading to death, with noapparent cause other than that of vascular 
origin” is still frequently used.(4) This definition has been accepted by neurology community for more than 40 years 
despite many pitfalls. Firstly, this definition stresses on focal or global cerebral dysfunction and did not include stroke 
caused bybrainsten, retinal or spinal cord vascular events. Secondly, few vascular events may present with headache 
without causing focal or global cerebral dysfunction such as mild cases of cerebral venous thrombosis and subarachnoid 
hemorrhage and would not fulfill this WHO definition. Thirdly, old definition also did not address silent infarction and 
silent cerebral hemorrhage found on neuroimaging or neuropathological examination.Fourthly, another component of 
this definition i.e. “global cerebral dysfunction” occurs only in special setting such as severe hypotension and after a 
period of cardiac arrest causing global cerebral ischemia and, in strict sense, is not a stroke syndrome. As a result 
oldest WHO definition of stroke has become outdated, obsolete and needed reformulation. First definition of transient 
ischemic attacks “TIAs” was proposed in 1964 by J. Marshall and defined such attacks as “a disturbance of neurological 
function of less than 24 hours’ duration occurring in the territory of supply of the carotid or vertebrobasilar arteries.”(5) 
In 1975, an Ad Hoc Committee on Cerebrovascular Disease published the following definition: “Transient ischemic 
attacks are episodes of temporary and focal dysfunction of vascular origin, which are variable in duration, commonly 
lasting from 2 to 15 minutes, but occasionally lasting as long as a day (24 hours). They leave no persistent neurological 
deficit”.(6) When this definition was formulated, diagnostic techniques were unavailable that could determine the 
presence of brain infarction. The definition of TIA that was used in the 1975 report was universally cited until the beginning 
of the 21st century. There were two pitfalls in old definition of TIAs: duration of TIAs and lack of imagingfindings. As 
neurological deficit may recover completely clinicallywith in24 hours but imaging may show evidence of infarction. 
Frequency of DWI abnormality in patients withtransient neurological episodes of different durations was found between 
30-51% in a pooled analysis from 10 MRI Studies enrolling 818 patients.(7) During the last 40 years, lot of development 
and progress has been made in understanding stroke and therapeutic approaches to stroke.New techniques in imaging 
have been developed with better understanding of stroke syndrome that has prompted attempts at new redefinition of 
“Stroke” and “TIAs”.The Stroke Council of the American Heart Association/American Stroke Association convened a 
writing group to develop an expert consensus document for an updated definition of stroke for the 21st century. In this 
editorial I would highlight some of these new definitions of stroke related syndromes as formulated by expert panel and 
has already been published in journal of “Stroke”.(8) The updated definition of stroke incorporates clinical and tissue 
criteria especially imaging. The term “Stroke” is broadly applicable to include all cases of CNS infarction, intracerebral 
hemorrhage, and subarachnoid hemorrhage. Central nervous system infarction is defined as brain, spinal cord, or 
retinal cell death attributable to ischemia, based on neuropathological, neuroimaging, and/or clinical evidence of 
permanent injury (i.e symptoms persisting ≥24 hours or until death, and other etiologies excluded). CNS infarction also 
includes hemorrhagic infarctions, types I and II. Ischemic stroke specifically refers to central nervous system infarction 
accompanied by overt symptoms. Almost 50 years ago, Fisher first described the presence of cerebral infarction in the 
absence of any clinically apparent stroke or transient ischemic attack. (9) It is only in recent years with major advances 
in imaging technology, however, that ‘silent’ brain infarcts (SBI) have been studied in any detail. Silent CNS infarction 
is defined as imaging or neuropathological evidence of CNS infarction, without a history of acute neurological dysfunction 
attributable to the lesion.The prevalence of SBI ranges from 5% to 62% in populationbased cohorts, most estimates 
falling in the 10% to 20% range. Longitudinal studies suggest an annual incidence between 2% and 4%. (10) Silent 
brain infarcts increase the risk of clinical infarction by 2 to 4 times in population-based studies.(11) This led to incorporation 
of brain infarction into the ABCD system (ABCD2I score) which improved prediction of stroke in the acute phase after 
transient ischemic attack.(12) The presence of hemorrhage in ischemic infarction has forced many treating physicians 
to stop ischemic treatment till hemorrhage is resolved. This hemorrhagic transformation of ischemic infarction has also 
been more clearly defined in two categories i.e. hemorrhagic infarction and parenchymal hemorrhage with clear guidelines 
regarding continuation or discontinuation of anti thrombotic treatment. “Hemorrhagic infarction” is defined as hemorrhage 
that may occur after infarction, either spontaneously or caused by antithrombotic or thrombolytic therapy. Hemorrhagic 
infarction is characterized by its lack of mass effect. Hemorrhagic infarction type I is defined by petechiae of blood along 
the margins of the infarction, whereas type II has confluent petechiae within the infarction but without a space occupying 
effect. Despite presence of hemorrhage these patients are treated according to ischemic protocol and are considered 
cerebral infarctions.In contrast, parenchymal hemorrhage is defined by the presence of mass effect, similar to the ICH 
definition of a focal collection of blood. Parenchymal hemorrhage type-I is a confluent hemorrhage limited to ≤30% of 
the infarcted area with only mild space-occupying effect, and type II is >30% of the infarcted area and/or exerts a 
significant space-occupying effect. These parenchymal hemorrhages parenchymal hemorrhages should be considered 
ICHs and may require reversal of antithrombotic therapy, aggressive antihypertensive therapy, and/or anti-edema 
therapy’.Similary stroke due to intracerebralhemoorhage, Subarachnoid hemorrhage, Cerebral venous thrombosis and 
Stroke, not otherwise specified has been redfined by the expert panel.(8) At the end I would like to highlight recent 
definitions of TIA. In 2002, an expert committee proposed a new definition: “A TIA is a brief episode of neurologic 
dysfunction caused by focal brain or retinal ischemia, with clinical symptoms typically lasting less than one hour, and 
without evidence of acute infarction”.(13) In 2009, an expert committee of the American Heart Association/American 
Stroke Association published a scientific statement defining TIA and recommending evaluation. The definitionof  transient 
ischemic attack (TIA) proposed was: “a transient episode of neurological dysfunction caused by focal brain, spinal cord, 
or retinal ischemia without acute infarction”.(14) Because of the variability of duration ; there is now general agreement 
that a fixed time designation should not be the primary distinguishing factor between stroke and TIA. Time should be a 
secondary consideration when adequate imaging is unavailable. Future implications of new definitions for physicians in 
Pakistan. The new definitions rely more on imaging techniques especially DWI and / or PWI MRI which can detect infarction 
within few minutesafter the arterial occlusion and even in patients who had transient vascular event on clinical ground.  
In Pakistan, neurological services are available only in main teaching hospitals and MRI facilities are limited to major 
cities. More over the use of thrombolytic therapy for acute stroke is even rare in the country. Under these circumstances 
treating physician would have no choice to adhere to the older definitions which are more clinical than imaging or tissue 
based. How we need to develop the neurological services in the country and update the knowledge of physicians with 
new trends and development in the world.
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INTRODUCTION
Stroke is one of the most leading causes of mortality 
and disability in the world. (1) Many patients are left with 
residual cognitive deficits such as personality disorders, 
depression and memory loss after acute phase of 
stroke (2, 3). Post stroke dementia (PSD) is the second 
most common cause of dementia (4) and one of the 
main causes of dependency in survivors and includes 
any dementia after a stroke, irrespective of its cause (5). 
In Europe and North America, Alzheimer's disease 
predominates over PSD in a 2:1 ratio; in contrast, in 
some Asian countries PSD accounts for almost 50% of 
all dementias (6). Its prevalence ranges from 6 to 32% (7) 
and it has been found to be higher than previously 
expected, and a stroke increases the risk of dementia 4 
to 12 times (8). The diagnosis of PSD is based on the 
patient history, the clinical evaluation and neuroimaging 
(9), and it is   associated with high rates morbidity and 
mortality (2). Then, it is important to determine its risk 
factors. Some demographic, genetic and lesion-related 
radiological factors have been reported to predict 
dementia in stroke patients, but there has not been a 
consensus about them  (10, 11). Realizing the importance 
of research in this filed and lack of any published 
studies  about PSD from Iran , we decided to evaluate 
the prevalence of PSD  and some of  its putative  risk  
factors. To our knowledge, this is the first hospital-
based study among Iranian population about PSD.
METHODS 
1. Subjects 
This cross-sectional study was conducted on 151 
patients with first-ever stroke in Rafsanjan (south of 
Iran). Patients with a clinical suspicion of stroke under-
went neuroimaging (CT scan and MRI) and the diagnosis 
was confirmed by them. All patients with history of any 
underling disease especially dementia and mild cognitive 
impairment were excluded from the study except 
patients with ischemic heart disease (IHD), diabetes 
(DM), hypertension (HTN) and hyperlipidemia (HLP). 
Other exclusion criteria were history of opium or other 
substance addiction, inadequate vision and hearing, 
aphasia   any drug consumption (except drugs were 
used for treatment of IHD, DM, HTN, HLP) such as 
antipsychotic and anti depressant. The ethics committee 
of Yazd branch of Islamic Azad University had confirmed 
the research. 
2. Clinical characteristics
Following information was collected for each patient: 
baseline demographics (age, gender and educational 
status), stroke type according to Oxfordshire Community 
Stroke Project Classification. The subjects were 
screened for PSD using the DSM-IV at three months.
3. Statistical analysis
To analyze the data, descriptive statistics, and 
chi-square test were used and p≤0.05 was considered   
statistically significant.
RESULTS 
In our study, 71(47%) patients were male and the rest 
were80 (53%) female. Mean age of men and women 
were 65.5 and 66.5 years, respectively. 35 (23.2%)   
patients had PSD after three months. 70.6 % of 
patients were 60 years old or more. 88.7% of patients 
had ischemic infarction and the others had hemor-
rhagic stroke. The most frequent lesion locations were 
temporal, frontal and parietal lobes respectively. There 
was no significant statistical difference between PSD 
and sex, age, educational status, lesion location and 
kind of stroke. (Table 1)
Table1: Frequency of risk factors in patients 
CONCLUSION
In our hospital-based study prevalence of PSD was 
23.2 % . This finding shows that a significant portion of 
patients with stroke are prone to PSD. We did not find 
any published article about PSD concerning the Iranian 
population; it seems that in Iranian population, our 
study is the first in this field but many studies have been 
conducted in other countries. Prevalence of PSD is 
reported to be between 7% and 41%, (10). Some studies 
show the same frequency of PSD as our study, such as 
those conducted in Italy (24.6%) and America (26.3%) 
(12,13 ) where as others show lower prevalence such as 
Portugal( 5.9% ) and Taiwan( 9.2%) (14, 15) or higher in 
Finland (31.8%) (16). In a systematic review ,the prevalence 
of post stroke memory dysfunction varied from 23% to 
55% 3 months post stroke, which declined from 11% to 
31% 1 year post stroke.(17 ). The prevalence of dementia 
among people with a history of stroke is similar to that 
observed in subjects 10 years older without a history of 
stroke (18). Also, several studies have confirmed that 
stroke doubles the probability of developing dementia 
and that risk is higher in the first 6-12 months and in a 
community based study done over 25 years, the cumu-
lative incidence of PSD was 7% after 1 year, 10% after 
3 years, 15% after 5 years, 23% after 10 years, and 
48% after 25 years (19 ) These discrepancies may be   
related to different population studies, different criteria 
used for the diagnosis of dementia  and different time 
interval between stroke and the neuropsychological 
assessment (20). Although, stroke was recognized as an 
important cause of dementia more than a century ago 
(21), many aspects of PSD pathophysiology are not clear. 
The causes of PSD are multifactorial and involve 
neuronal networks needed for memory (22). Disturbance 
in some neurotransmitters (6), genetic factors (23), direct 
neuronal damage and impaired vascular autoregulatory 
mechanisms are some factors involved in PSD pato-
physiology. (2, 24, 25) Our results showed that PSD can be 
seen in both ischemic and hemorrhagic lesions. The 
risk and severity of cognitive disturbances occurring 
after a stroke do not seem to be influenced by type of   
stroke (ischemic or hemorrhagic) (8, 13, 14). In most 
studies such as ours, no gender specifity was observed 
(15,21). Similarly, many studies did not find any relation-
ship between location of the vascular lesion and PSD 
(14,15,21). Higher educational attainment has been found 
to be a protective factor for PSD (5) however, we could 
not ascertain this effect in our study and neither could 
the research performed in Spain (21). Although we did 
not find a relationship between age and dementia, 
some have studies suggested an association between 
the two (11, 21). It should be mentioned that  controversies 
about age, sex, location of lesion and educational 
status are frequent(7 ,11), and some factors such as  
dysphasia, hemiparesis, hemianopia (10), silent infarcts, 
cortical cerebral atrophy (26) medial temporal lobe atrophy 
and white matter changes , have been associated with 
an increased risk to develop PSD in some studies(19). 
Our study had some limitations. First, our study was a 
cross-sectional study. Second; we fallowed the patients 
only three months. Third, patients with aphasia were 
excluded from our study. These limitations may have 
some effects on the results. In conclusion, our study 
showed high prevalence of PSD in Iranian population. 
Both ischemic and hemorrhagic lesions have a similar 
effect on PSD and early recognition and treatment of 
PSD risk factors will definitely improve the quality of life 
of the patients.  
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INTRODUCTION
Stroke is one of the most leading causes of mortality 
and disability in the world. (1) Many patients are left with 
residual cognitive deficits such as personality disorders, 
depression and memory loss after acute phase of 
stroke (2, 3). Post stroke dementia (PSD) is the second 
most common cause of dementia (4) and one of the 
main causes of dependency in survivors and includes 
any dementia after a stroke, irrespective of its cause (5). 
In Europe and North America, Alzheimer's disease 
predominates over PSD in a 2:1 ratio; in contrast, in 
some Asian countries PSD accounts for almost 50% of 
all dementias (6). Its prevalence ranges from 6 to 32% (7) 
and it has been found to be higher than previously 
expected, and a stroke increases the risk of dementia 4 
to 12 times (8). The diagnosis of PSD is based on the 
patient history, the clinical evaluation and neuroimaging 
(9), and it is   associated with high rates morbidity and 
mortality (2). Then, it is important to determine its risk 
factors. Some demographic, genetic and lesion-related 
radiological factors have been reported to predict 
dementia in stroke patients, but there has not been a 
consensus about them  (10, 11). Realizing the importance 
of research in this filed and lack of any published 
studies  about PSD from Iran , we decided to evaluate 
the prevalence of PSD  and some of  its putative  risk  
factors. To our knowledge, this is the first hospital-
based study among Iranian population about PSD.
METHODS 
1. Subjects 
This cross-sectional study was conducted on 151 
patients with first-ever stroke in Rafsanjan (south of 
Iran). Patients with a clinical suspicion of stroke under-
went neuroimaging (CT scan and MRI) and the diagnosis 
was confirmed by them. All patients with history of any 
underling disease especially dementia and mild cognitive 
impairment were excluded from the study except 
patients with ischemic heart disease (IHD), diabetes 
(DM), hypertension (HTN) and hyperlipidemia (HLP). 
Other exclusion criteria were history of opium or other 
substance addiction, inadequate vision and hearing, 
aphasia   any drug consumption (except drugs were 
used for treatment of IHD, DM, HTN, HLP) such as 
antipsychotic and anti depressant. The ethics committee 
of Yazd branch of Islamic Azad University had confirmed 
the research. 
2. Clinical characteristics
Following information was collected for each patient: 
baseline demographics (age, gender and educational 
status), stroke type according to Oxfordshire Community 
Stroke Project Classification. The subjects were 
screened for PSD using the DSM-IV at three months.
3. Statistical analysis
To analyze the data, descriptive statistics, and 
chi-square test were used and p≤0.05 was considered   
statistically significant.
RESULTS 
In our study, 71(47%) patients were male and the rest 
were80 (53%) female. Mean age of men and women 
were 65.5 and 66.5 years, respectively. 35 (23.2%)   
patients had PSD after three months. 70.6 % of 
patients were 60 years old or more. 88.7% of patients 
had ischemic infarction and the others had hemor-
rhagic stroke. The most frequent lesion locations were 
temporal, frontal and parietal lobes respectively. There 
was no significant statistical difference between PSD 
and sex, age, educational status, lesion location and 
kind of stroke. (Table 1)
Table1: Frequency of risk factors in patients 
CONCLUSION
In our hospital-based study prevalence of PSD was 
23.2 % . This finding shows that a significant portion of 
patients with stroke are prone to PSD. We did not find 
any published article about PSD concerning the Iranian 
population; it seems that in Iranian population, our 
study is the first in this field but many studies have been 
conducted in other countries. Prevalence of PSD is 
reported to be between 7% and 41%, (10). Some studies 
show the same frequency of PSD as our study, such as 
those conducted in Italy (24.6%) and America (26.3%) 
(12,13 ) where as others show lower prevalence such as 
Portugal( 5.9% ) and Taiwan( 9.2%) (14, 15) or higher in 
Finland (31.8%) (16). In a systematic review ,the prevalence 
of post stroke memory dysfunction varied from 23% to 
55% 3 months post stroke, which declined from 11% to 
31% 1 year post stroke.(17 ). The prevalence of dementia 
among people with a history of stroke is similar to that 
observed in subjects 10 years older without a history of 
stroke (18). Also, several studies have confirmed that 
stroke doubles the probability of developing dementia 
and that risk is higher in the first 6-12 months and in a 
community based study done over 25 years, the cumu-
lative incidence of PSD was 7% after 1 year, 10% after 
3 years, 15% after 5 years, 23% after 10 years, and 
48% after 25 years (19 ) These discrepancies may be   
related to different population studies, different criteria 
used for the diagnosis of dementia  and different time 
interval between stroke and the neuropsychological 
assessment (20). Although, stroke was recognized as an 
important cause of dementia more than a century ago 
(21), many aspects of PSD pathophysiology are not clear. 
The causes of PSD are multifactorial and involve 
neuronal networks needed for memory (22). Disturbance 
in some neurotransmitters (6), genetic factors (23), direct 
neuronal damage and impaired vascular autoregulatory 
mechanisms are some factors involved in PSD pato-
physiology. (2, 24, 25) Our results showed that PSD can be 
seen in both ischemic and hemorrhagic lesions. The 
risk and severity of cognitive disturbances occurring 
after a stroke do not seem to be influenced by type of   
stroke (ischemic or hemorrhagic) (8, 13, 14). In most 
studies such as ours, no gender specifity was observed 
(15,21). Similarly, many studies did not find any relation-
ship between location of the vascular lesion and PSD 
(14,15,21). Higher educational attainment has been found 
to be a protective factor for PSD (5) however, we could 
not ascertain this effect in our study and neither could 
the research performed in Spain (21). Although we did 
not find a relationship between age and dementia, 
some have studies suggested an association between 
the two (11, 21). It should be mentioned that  controversies 
about age, sex, location of lesion and educational 
status are frequent(7 ,11), and some factors such as  
dysphasia, hemiparesis, hemianopia (10), silent infarcts, 
cortical cerebral atrophy (26) medial temporal lobe atrophy 
and white matter changes , have been associated with 
an increased risk to develop PSD in some studies(19). 
Our study had some limitations. First, our study was a 
cross-sectional study. Second; we fallowed the patients 
only three months. Third, patients with aphasia were 
excluded from our study. These limitations may have 
some effects on the results. In conclusion, our study 
showed high prevalence of PSD in Iranian population. 
Both ischemic and hemorrhagic lesions have a similar 
effect on PSD and early recognition and treatment of 
PSD risk factors will definitely improve the quality of life 
of the patients.  
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